- United Kingdom - Solicitors
- United Kingdom - The Bar
- United States
- Canada
- Caribbean
- Deutschland
- Paris
- Tax Directors Handbook
- What is The Legal 500?
- Meet the team
- How can my law firm get involved?
- Research calendar
- The Legal 500 on Twitter
- Contact us
- Other Legalease products
ABOUT US
- The Legal Business Awards 2018
- Enterprise GC 2018
- The Legal 500 UK Awards 2018
- GC Summit Switzerland 2018
- Tokyo Anti-Corruption Forum 2018
- Dubai Roundtable: Doing business in North Afrida
- Beijing Life Sciences and Healthcare Roundtable 2018
- Discussing the future of disputes in the UK
- The Commercial Litigation Summit
- Leadership insight
- Human rights insight
- MINT: the legal challenges of working and investing in emerging economies
- Response to Brexit
- An investigation of the GCC and Middle East legal market
- Litigation and regulatory challenges in financial services
- AI and the law tools of tomorrow:
A special report - Scottish GCs
- North West clients
- COMPANIES
- Weil, Gotshal & Manges LLP
- Baker McKenzie
- DLA Piper
- Eversheds Sutherland
- RPC
- Clifford Chance
- KPMG
- Hewlett Packard Enterprise
- PayPal
- GC DIVERSITY AND INCLUSION REPORTS
- Shaping diversity
- A Numbers Game: Diversity in Europe
- Barbara Levi Mager describes Sandoz's approach to diversity
- Tony West is using his experience to improve diversity and inclusion within PepsiCo
- Prash Naik (Channel 4) talks about the 360 Diversity Charter
- Ian Johnson explains the strategic importance of inclusive work environments
- GC AUTUMN 2018
-
TENCENT ON THE DOLLAR
- Finding Fintech
- Japan's New Future
- The Price of Piety
- Billion Dollar Game
Lawyer rankings
David McIntosh
Position
David advises a wide range of companies, investors, and institutions in all manner of transactions involving intellectual property, including technology licensing, product development collaborations, outsourcing transactions, joint ventures, mergers and acquisitions, supply arrangements, distribution and co-promotion deals, and other strategic commercial agreements. David has extensive experience advising companies in the life sciences, technology, and branded product industries with respect to the creation and management of intellectual property, and day-to-day commercial and corporate matters. David also advises major life sciences, technology, branded product, retail, and financial services companies in connection with privacy and data security matters, including the design and implementation of global privacy and data security programs, privacy issues related to marketing and social media initiatives, and notice issues following data security breaches. - See more at: https://www.ropesgray.com/biographies/m/McIntosh-David.aspx?AK=mcintosh#sthash.65UmKRQy.dpuf
United States: Industry focus
Healthcare: life sciences
Within: Healthcare: life sciences
Ropes & Gray LLP’s team often advises clients on high-profile corporate and litigation matters. Co-chair Gregory Levine, along with Zach Blume and Paul Kinsella, led advice to Aegerion Pharmaceuticals on various contentious and non-contentious issues, including the negotiation of a consent decree with the FDA and DOJ. Michael Beauvais assisted Bain Capital with a $55m financing and investment round for German biopharmaceutical company InflaRx. David McIntosh acted for Akebia Therapeutics on various corporate transactions, including a number of major licensing agreements. The team, which includes the well-regarded Steven Wilcox, Mark Bellomy and Marc Rubenstein, was bolstered by the arrivals of Paul Scrivano in San Francisco from O'Melveny & Myers LLP and David Blittner in New York from Weil, Gotshal & Manges LLP. All partners are based in Washington DC and Boston unless otherwise stated.
United States: Intellectual property
Patents: licensing
Within: Patents: licensing
Ropes & Gray LLP is active in the pharmaceutical, life sciences and technology sectors. The firm’s main presence is in Boston where practice head David McIntosh and Mark Bellomy are based. Silicon Valley’s Megan Baca is also noted. A major highlight was assisting Akebia Therapeutics with its $1bn collaboration licence agreement with Otsuka Pharmaceutical for the development and commercialisation of an aenemia drug treatment, one of several strategic licence agreements that the client entrusted the practice with. In other work, Edward Black led in advising investment managing firm Tudor Investment on a collaboration agreement with an engineering firm in the field of artificial intelligence to advance trading strategies. Other clients include AMAG Pharmaceuticals, Lantheus Holdings and TPG Capital. James McGraw joined Gray Reed.
United States: M&A/corporate and commercial
Commercial deals and contracts
Within: Commercial deals and contracts
Known for its life sciences expertise, Ropes & Gray LLP’s practice handles a wide range of licensing and commercial agreements. Practice head Edward Black led advice to Tudor Investment Corporation on various IP transactions, including drafting agreements regarding a collaboration with an engineering firm. The group acted for Bain Capital Private Equity in all aspects arising from its acquisition of Innocor from a Sun Capital Partners affiliate. Mark Bellomy was engaged by Sarepta Therapuetics on the company’s sponsored research and option agreement with Généthon. David McIntosh and Silicon Valley-based Megan Baca are key names. All other partners are based in Boston. Other clients include Akebia Therapuetics, Pfizer and Juno Therapeutics.